U.S. market for polymeric (plastic) foams to grow 8.5 billion pounds by 2015

The U.S. market for polymeric (plastic) foams was about 7.4 billion pounds in 2009 and is expected to reach 7.5 billion pounds in 2010 and 8.5 billion pounds by 2015, a compound annual growth rate (CAGR) of 2.5% over the next 5 years.

Learn about the most important technological, economic, political, and environmental considerations in the U.S. polymeric foams industry and get information on the polymeric foams market by material types and by application along with relevant company profiles...

Use this report to:

• Learn about the significant changes that have occurred in this major segment of the plastics production and processing industry
• Navigate the environmental, regulatory, and public policy issues that are of increasing importance to the polymer foams industry
• Capture your share of newer markets, such as cross-linked polyolefin foam in leisure and sports goods, and foams made from biopolymers and biodegradable polymers to reduce the country’s dependency on petroleum and natural gas
• Formulate business plans based on forecasts for plastic foams of several kindsin many different important markets such as construction, transportation, and packaging.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

Global market for Musculoskeletal Disease to reach $57 billion by 2014

The global market for Musculoskeletal Disease was about $45 billion in 2009 and is expected to reach $57 billion by 2014, a compound annual growth rate (CAGR) of around 5% from 2009 through 2014.

Learn about the current pipeline of therapeutics and biomaterials utilized in the treatment of Musculoskeletal Diseases (MSDs), analyze the market and forecast for MSD therapeutics and treatments, and outline the key factors that will influence this therapeutic area in the next few years...

Use this report to:

• Assess the growth potential of musculoskeletal disease treatments over a 5-year period and understand the key factors that will influence this therapeutic area
• Learn how advances in biomaterials are being translated into viable products in the orthobiologics area, changing the way a number of related disease states are treated and creating more therapies and market opportunities
• Identify which marketing and distribution partnerships, technology platforms, and product development programs are likely to yield new targets and drugs that will reach the market in the next few years
• Formulate marketing and business plans based on usage projections in the major primary and secondary disease application areas.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

Global sales of Velcade to reach $3 billion by 2015

The global sales of Velcade (a proteasome inhibitor) was about $1.4 billion in 2009 and is expected to reach $3 billion in 2015, a compound annual growth rate (CAGR) of 13.5% through 2015.

Learn about the current state of drug discovery in the ubiquitin proteasome research field, existing products on the market, and detailed analysis of the competitive environments, including new potential markets for current research projects. This report includes information about significant players in this field of study, trends, and challenges, and other information affecting drug discovery in the ubiquitin proteasome system (UPS)...

Use this report to:

• Understand this emerging area of drug discovery and development
• Learn about the major research trends in UPS that are going to affect further drug development in this area, identification of new drug candidates, and new technologies in assay development
• Develop strategies and tools to evaluate potential commercial opportunities in this new field
• Gain insight into competitors’ positions and which companies are closest to introducing new products to the market in the next couple of years.

To provide further information about this report we offer a Complimentary Introduction, available from our Website.